Oppenheimer Lowers Amrize (NYSE:AMRZ) Price Target to $65.00

Amrize (NYSE:AMRZ) had its price objective reduced by stock analysts at Oppenheimer from $68.00 to $65.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 33.05% from the company’s previous close.

Other equities research analysts also recently issued research reports about the company. Truist Financial reaffirmed a “hold” rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a report on Tuesday, July 7th. Vertical Research raised Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target for the company in a report on Friday, May 1st. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Wells Fargo & Company dropped their price objective on Amrize from $65.00 to $58.00 and set an “overweight” rating for the company in a research report on Wednesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research note on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $62.79.

Amrize Price Performance

Shares of NYSE:AMRZ traded up $0.06 during midday trading on Tuesday, hitting $48.85. The stock had a trading volume of 3,090,092 shares, compared to its average volume of 3,155,867. The company’s 50-day moving average price is $52.24 and its 200-day moving average price is $55.27. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $27.02 billion and a P/E ratio of 23.40.

Amrize (NYSE:AMRZ) last posted its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, equities research analysts predict that Amrize will post 2.74 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Jan Philipp Jenisch acquired 21,417 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were bought at an average cost of $49.67 per share, with a total value of $1,063,782.39. Following the completion of the purchase, the chief executive officer directly owned 1,724,999 shares in the company, valued at $85,680,700.33. The trade was a 1.26% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, insider Mario Gross bought 2,800 shares of Amrize stock in a transaction that occurred on Tuesday, May 19th. The stock was bought at an average price of $49.17 per share, for a total transaction of $137,676.00. Following the completion of the acquisition, the insider directly owned 33,747 shares of the company’s stock, valued at $1,659,339.99. The trade was a 9.05% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 54,920 shares of company stock valued at $2,717,429 over the last three months. 0.54% of the stock is owned by insiders.

Hedge Funds Weigh In On Amrize

Hedge funds have recently bought and sold shares of the company. MCF Advisors LLC acquired a new position in Amrize in the fourth quarter valued at $27,000. Basepoint Wealth LLC acquired a new stake in Amrize during the 4th quarter worth about $33,000. Laurel Wealth Advisors LLC acquired a new stake in Amrize during the 4th quarter worth about $34,000. US Bancorp DE bought a new position in shares of Amrize in the 3rd quarter worth about $38,000. Finally, Itau Unibanco Holding S.A. lifted its stake in shares of Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after purchasing an additional 450 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.